QueryLift Raises ¥100 Million in Seed Funding
QueryLift, a Tokyo-based company specializing in AI-driven analysis platforms, has successfully raised ¥100 million in a seed funding round. The investment was led by JAFCO and Z Venture Capital, announced on September 18, 2026. The company, co-founded by Souta Noguchi, focuses on monitoring and analyzing how generative AI systems mention and cite companies and products.
Company Overview
QueryLift operates a platform that scrutinizes the responses from generative AI systems such as ChatGPT and Gemini. This platform evaluates how these AI systems reference companies and products, providing insights into citation bases and competitive comparisons. The data gathered is used to enhance web content, generate new content ideas, and verify changes post-publication.
Use of Funds
The fresh capital will be directed towards advancing research and development in natural language processing and information retrieval. QueryLift plans to integrate these advancements into their existing platform to enhance its capabilities. Furthermore, the company aims to bolster its sales and implementation support for large enterprises, ensuring a smoother adoption of its platform.
Future Plans
QueryLift is working on developing a new feature known as the "GEO Agent." This tool is designed to autonomously progress from data analysis to improvement and effect verification. Additionally, the company is looking to establish a decision-making foundation for optimizing indicators and selecting strategies tailored to specific objectives.
Industry Impact
QueryLift's platform has already been deployed by political parties, government agencies, and major corporations. Notably, it has contributed to a significant improvement in the citation rate of the Liberal Democratic Party’s official website in AI-generated responses, achieving a 2.7-fold increase in just four months. Moreover, one of its research outcomes has been recognized at the international conference on information retrieval and knowledge management, CIKM 2026.